Rodriguez, Anthony .
HRN: 25-74-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2024
CEFUROXIME 750MG (VIAL)
08/22/2024
08/29/2024
IV
750 Mg
Q 8h
MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes